Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Vet Comp Oncol. 2013 Mar 12;13(3):166–175. doi: 10.1111/vco.12031

Figure 3. Evaluation of sensitivity of canine primary OSA cell lines associated with normal or increased serum ALP to doxorubicin chemotherapy.

Figure 3

There is no difference in sensitivity to increasing doxorubicin concentrations (0.01–1μM) between canine primary OSA cell lines associated with normal or increased serum ALP concentration under: (A) 10% FBS-containing media conditions, or (B) 1% FBS-containing media conditions. Comparisons made using two-way ANOVA testing.